IRRAS announces changes in management and key hires with leadership roles in Regulatory Affairs and Hummingbird Product Line
Stockholm, September 13, 2019 – IRRAS AB, a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that Vinny Podichetty VP, Clinical, Regulatory Affairs & Quality has resigned for personal reasons, and two key appointments to drive IRRAS’ continued growth. Niloufa Insanally, Ph.D., joins as Head of Regulatory Affairs. Dr. Insanally has over 15 years’ experience in the medical device, pharmaceutical and biotechnological areas with extensive expertise with both US and international regulatory approval